EHTH
eHealth, Inc.
There isn't enough reported data to score EHTH yet.
MS
Morgan Stanley
MS's fundamentals are strong: revenue grew 16% and earnings per share grew 29%. At 15x earnings, it's trading in line with its usual 14x. Analysts expect earnings growth.
EHTH Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Stable | |
| N/A | |
| N/A |
EHTH's profitability is currently stable, but its revenue is weak. Free cash flow and net leverage aren't meaningful measures for financial services companies like EHTH.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
EHTH PE Valuation
EHTH has no meaningful PE right now: it lost money over the past year.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
EHTH Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Decline | |
| Improving | |
| Limited | |
| High |
Analysts expect EHTH's earnings to grow and its profitability to improve, but its revenue to decline.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
MS has the edge over EHTH on the outlook, with more favorable revenue expectations.
EHTH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.82 | — |
| Q4 2024 | -$1.19 | +$1.18 |
| Q3 2024 | -$2.62 | +$0.78 |
| Q2 2024 | -$2.47 | +$0.97 |
| Q1 2024 | -$2.32 | +$1.59 |
| Q4 2023 | -$2.37 | +$1.99 |
| Q3 2023 | -$3.40 | +$2.89 |
| Q2 2023 | -$3.44 | +$3.37 |
| Q1 2023 | -$3.91 | +$2.11 |
MS has the stronger earnings trend. Trailing diluted EPS is down 150% for EHTH versus MS up 29%.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS's earnings per share have climbed steadily: $12.60 over the past year, up 29% from the year before, and higher year over year for 10 quarters in a row.
EHTH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $21.3M | -60% |
| Q2 2026 | $33.6M | -45% |
| Q1 2026 | $88M | -22% |
| Q4 2025 | $326.2M | +3.5% |
| Q3 2025 | $53.9M | -7.8% |
| Q2 2025 | $60.8M | -7.7% |
| Q1 2025 | $113.1M | +22% |
| Q4 2024 | $315.2M | +27% |
EHTH's revenue is shrinking: $21M last quarter, down 60% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -218% | -141 points |
| Q2 2026 | -82% | -44 points |
| Q1 2026 | -3.3% | -7.5 points |
| Q4 2025 | 39% | +3 points |
| Q3 2025 | -77% | -3.1 points |
| Q2 2025 | -38% | +4.5 points |
| Q1 2025 | 4.2% | +24 points |
| Q4 2024 | 36% | +12 points |
EHTH's operating margin was −218% last quarter, down 141 points from the same quarter a year ago, near the bottom of its range since 2019.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the edge over EHTH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS has the edge over EHTH on profitability, with a higher operating margin.
EHTH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$11.3M | +$14.3M |
| Q2 2026 | -$5.4M | +$37.3M |
| Q1 2026 | $35.6M | -54% |
| Q4 2025 | -$36.1M | -$7.8M |
| Q3 2025 | -$25.5M | +$4.8M |
| Q2 2025 | -$42.8M | -$10.3M |
| Q1 2025 | $76.8M | +8.9% |
| Q4 2024 | -$28.3M | +$5.4M |
EHTH has the edge over MS on cash flow, with more consistent year-over-year improvement.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
EHTH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.1% | +353K shares |
| 1 year | +5.7% | +1.7M shares |
| 3 years | +16% | +4.5M shares |
| 5 years | +21% | +5.5M shares |
| Available history | +31% | +7.6M shares |
EHTH has 32M diluted shares, up 5.7% from a year ago.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over EHTH on shareholder dilution, with a more favorable share count trend.
EHTH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.1x | Healthy |
| Q2 2026 | 0.8x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.1x | Very low |
| Q2 2025 | 0.1x | Very low |
| Q1 2025 | -1.0x | Net Cash |
| Q4 2024 | 0.8x | Very low |
EHTH has the edge over MS on leverage, with a lower net debt burden relative to earnings.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
EHTH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 22.2 | Oversold |
| Stochastic | 1.6 | Oversold |
EHTH's weekly RSI is 22 (oversold) and its Stochastic is 2 (oversold).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
EHTH PE vs Financial Services Sector
| Metric | EHTH | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
EHTH has no meaningful PE right now: it lost money over the past year.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
EHTH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.58 | 24% below |
| 20 week MA | $0.99 | 56% below |
| 50 week MA | $1.79 | 75% below |
| 100 week MA | $3.78 | 88% below |
| 200 week MA | $5.21 | 92% below |
EHTH is in a downtrend: it's below all five of its weekly moving averages, and 92% below its 200-week average.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS has the edge over EHTH on trend strength, trading above more of its moving averages.
EHTH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $94.4 | $73.9 | -22% |
| 2021 | $73.9 | $26.9 | -64% |
| 2022 | $26.9 | $4.43 | -84% |
| 2023 | $4.43 | $8.72 | +97% |
| 2024 | $8.72 | $8.65 | -0.8% |
| 2025 | $8.65 | $4.12 | -52% |
| 2026 YTD | $4.12 | $0.44 | -89% |
EHTH has finished lower in five of the last six years. It's down 89% so far in 2026.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has the edge over EHTH on returns for 2026, with the stronger performance.